SPRY2 and malignant colon neoplasm: Interestingly, in contrast to our results, SPRY2 can suppress both basal and 1α,25-dihydroxyvitamin D3-induced E-cadherin expression, and SPRY2 expression levels are negatively correlated with E-cadherin expression levels in human colon cancer cells [54].